newsfilter
← Latest News
Business Wire·

Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update

Varegacestat PDUFA target action date set for April 28, 2027, following U.S. FDA acceptance of New Drug Application (NDA) for adults with desmoid tumors Detailed Phase 3 RINGSIDE data presented in an oral session